A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseasesKitty J. Jager, Carmine Zoccali, Csaba P. Kövesdy et al.|Kidney International|2019Cited by 886
An introduction to inverse probability of treatment weighting in observational researchNicholas C Chesnaye, Kitty J. Jager, Vianda S Stel et al.|Clinical Kidney Journal|2021Cited by 877
External validation of prognostic models: what, why, how, when and where?Chava L. Ramspek, Merel van Diepen, Kitty J. Jager et al.|Clinical Kidney Journal|2020Cited by 808
When do we need competing risks methods for survival analysis in nephrology?Marlies Noordzij, Kitty J. Jager, Karen Leffondré et al.|Nephrology Dialysis Transplantation|2013Cited by 674
CKD Prevalence Varies across the European General PopulationKatharina Brück, Kitty J. Jager, Wim Van Biesen et al.|Journal of the American Society of Nephrology|2015Cited by 588